Skip to main content

1,25 dihydroxyvitamin D3 alone or in combination with parathyroid hormone does not increase bone mass in young rats

Calcified Tissue International volume 43, pages 284–288 (1988)Cite this article

Summary

Parathyroid hormone (PTH) alone is known to increase bone mass, but clinical studies of osteoporotic men suggest that when 1,25 dihydroxyvitamin D3 (1,25(OH)2D3) is given in combination with PTH, the effect on bone growth is enhanced. To determine if 1,25(OH)2D3 alone would stimulate bone growth, young male rats were given daily subcutaneous injections of either vehicle or 2.5, 5, 10, or 20 ng 1,25(OH)2D3 per 100 g body weight for 30 days. To determine if 1,25(OH)2D3 would augment the PTH anabolic response, rats were given daily subcutaneous injections of either vehicle for 12 days; or 4 μg/100 g hPTH alone or in combination with 5 ng/100 g 1,25(OH)2D3; or 8 μg/100 g hPTH alone or in combination with 5 ng/100 g 1,25(OH)2D3. Calcium (Ca), dry weight (DW), and hydroxyproline (Hyp) of the distal femur; the rate of mineralization in the metaphysis of the proximal tibia; and serum calcium and phosphate were measured. Low normocalcemic doses of 1,25(OH)2D3 did not significantly stimulate bone growth. 1,25(OH)2D3 did not augment the PTH-stimulated anabolic effect in young male rats. Low doses (2.5 and 5 ng) of 1,25(OH)2D3 were not hypercalcemic, and there was no increase in total bone calcium or dry weight although the 5 ng dose increased trabecular bone calcium. 1,25(OH)2D3 at 10 and 20 ng increased trabecular bone DW and Hyp, but mineralization was impaired and rats were hypercalcemic. 1,25(OH)2D3 in combination with PTH did not augment the PTH stimulation of bone growth as trabecular and cortical bone Ca, DW, and HYP were not increased in rats given both hPTH and 1,25(OH)2D3 compared with values for rats treated with hPTH alone.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Gunness-Hey M, Hock JM (1984) Increased trabecular bone mass in rats treated with human synthetic parathyroid hormone. Metab Bone Dis Rel Res 5: 177–181

    Article  CAS  Google Scholar 

  2. Podbesek R, Edouard C, Meunier PJ, Parsons JA, Reeve J, Stevenson RW, Zanelli JM (1983) Effects of two treatment regimes with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in greyhounds. Endocrinol 112: 1000–1006

    CAS  Google Scholar 

  3. Hefti E, Trechsel U, Bonjour JP, Fleisch H, Schenk R (1982) Increase of whole body calcium and skeletal mass in normal and osteoporotic adult rats treated with parathyroid hormone. Clin Sci 62: 389–396

    PubMed  CAS  Google Scholar 

  4. Hock JM, Gunness-Hey M, Poser J, Olson H, Bell NH, Raisz LG (1986) Stimulation of undermineralized matrix formation by 1,25-dihydroxyvitamin D3 in long bones of rats. Calcif Tissue Int 38: 79–86

    PubMed  CAS  Google Scholar 

  5. Boyce RW, Weisbrode SE (1983) Effect of dietary calcium on the bone response to 1,25(OH)2D3. Lab Invest 48: 683–689

    PubMed  CAS  Google Scholar 

  6. Gallagher JA, Beneton M, Harvey L, Lawson DEM (1986) Response of rachitic rat bones to 1,25-dihydroxyvitamin D3: biphasic effects on mineralization and lack of effect on bone resorption. Endocrinol 119: 1603–1609

    CAS  Google Scholar 

  7. Lindholm TS, Nilsson OS, Lindholm TC (1981) Effect of 1-alpha-hydroxyvitamin D3 on cancellous bone matrix. An experimental study in rats. Acta Orthop Scand 52: 497–503

    PubMed  CAS  Article  Google Scholar 

  8. Wronski TJ, Halloran BP, Bikle DD, Goblus RK, Morey-Holton ER (1986) Chronic administration of 1,25-dihydroxyvitamin D3: increased bone but impaired mineralization. Endocrinol 119: 2580–2585

    CAS  Google Scholar 

  9. Larsson SE, Lorentzon R, Boquist L (1977) Low doses of 1,25-dihydroxycholecalciferol increase mature bone mass in adult normal rats. Clin Orthop Rel Res 127: 228–235

    CAS  Google Scholar 

  10. Ott SM, Chesnut CH (1987) Calcitriol treatment does not increase bone mass in postmenopausal osteoporotic women. J Bone Min Res 2(suppl 1): 224A

    Google Scholar 

  11. Slovik DM, Rosenthal DI, Doppelt SH, Potts JT Jr, Daly MA, Campbell JA, Neer RM (1986) Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1–34) and 1,25-dihydroxyvitamin D. J Bone Min Res 1: 377–381

    CAS  Article  Google Scholar 

  12. Gunness-Hey M, Hock JM, Gera I, Fonseca J, Poser J, Bevan J, Raisz LG (1986) Human parathyroid hormone (1–34) and salmon calcitonin do not reverse impaired mineralization produced by high doses of 1,25-dihydroxyvitamin D3. Calcif Tissue Int 38: 234–238

    PubMed  Article  CAS  Google Scholar 

  13. Schmid RN, Reilly CN (1957) New complexion for titration of calcium in the presence of magnesium. Anal Chem 29: 264–268

    Article  CAS  Google Scholar 

  14. Belseyre RE, DeLuca HF, Potts JR (1974) A rapid assay for 25(OH)D3 without preparative chromatography. J Clin Endocrinol Metab 38: 1046–1051

    Google Scholar 

  15. Reinhardt TA, Horst RL, Orf JW, Hollis BW (1984) A microassay for 1,25 dihydroxyvitamin D3 not requiring high performance liquid chromatography: application to clinical studies. J Clin Endocrinol Metab 58: 91–98

    PubMed  CAS  Article  Google Scholar 

  16. Cheng PM (1969) An improved method for the determination of hydroxyproline in rat skin. Dermatologica 53: 112–115

    CAS  Google Scholar 

  17. Snedecor GW, Cochran WC (1967) Statistical methods. Iowa State University Press, Ames, Iowa

    Google Scholar 

  18. Steel RGD, Torrie JH (1980) Principles and procedures of statistics: a biometrical approach. McGraw-Hill, New York

    Google Scholar 

  19. Gallagher JC, Riggs BL, Eisman J, Hamstra A, Arnaud SB, DeLuca HJ (1979) Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients. Effects of age and dietary calcium. J Clin Invest 64: 729–736

    PubMed  CAS  Article  Google Scholar 

  20. Recker RR, Gallagher JC, Heaney RP (1984) The metabolic effects of treatment with calcitriol in patients with postmenopausal osteoporosis. Clin Res 32: 406A

    Google Scholar 

  21. Gallagher JC, Jerpbak CM, Jee WSS, Johnson KA, DeLuca HF, Riggs BL (1982) 1,25-dihydroxyvitamin D3: short- and long-term effects on bone and calcium metabolism in patients with postmenopausal osteoporosis. Proc Natl Acad Sci (USA) 79: 3325–3329

    Article  CAS  Google Scholar 

  22. Reeve J, Arlot M, Bernat M, Charhon S, Edouard C, Slovik D, Vismans J, Meunier PJ (1981) Calcium-47 kinetic measurements of bone turnover compared to bone histomorphometry in osteoporosis: the influence of human parathyroid fragment (hPTH 1–34) therapy. Metab Bone Dis Rel Res 3: 23–30

    Article  CAS  Google Scholar 

  23. Reeve J, Zanelli JM (1986) Parathyroid hormone and bone. Clin Sci 71: 231–238

    PubMed  CAS  Google Scholar 

  24. Malluche HH, Matthews C, Faugere M-C, Fanti P, Endres DB, Friedler RM (1986) 1,25-dihydroxyvitamin D maintains bone cell activity, and parathyroid hormone modulates bone cell number in dogs. Endocrinology 119: 1293–1304

    Google Scholar 

  25. Ambrecht HJ (1986) Age-related changes in calcium and phosphorus uptake by rat small intestine. Biochem Biophys Acta 882: 281–286

    Google Scholar 

Download references

Author information

Affiliations

  1. School of Medicine, University of Connecticut Health Center, Farmington, Connecticut

    M. Gunness-Hey & L. G. Raisz

  2. Semmelweis Medical University, Budapest, Hungary

    I. Gera

  3. Veterans Administration Medical Center, Newington, Connecticut

    J. Fonseca & J. M. Hock

  4. School of Dental Medicine, University of Connecticut Health Center, Farmington, Connecticut, USA

    J. Fonseca & J. M. Hock

Authors
  1. M. Gunness-Hey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. Gera
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Fonseca
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. G. Raisz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. M. Hock
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Gunness-Hey, M., Gera, I., Fonseca, J. et al. 1,25 dihydroxyvitamin D3 alone or in combination with parathyroid hormone does not increase bone mass in young rats. Calcif Tissue Int 43, 284–288 (1988). https://doi.org/10.1007/BF02556637

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02556637

Key words

  • PTH
  • 1,25(OH)2D3
  • Bone formation
  • Rats